Cynapsus Therapeutics Company
Cynapsus is a pharmaceutical company that focuses on developing a non-injectable drug for Parkinson–≤–Р–©s disease.
Industry:
PharmTech
Technology:
Biologics
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Investors Number:
3
Headquarters:
Canada
Employee Number:
11-50
Investor Type:
For Profit
Total Funding:
$23.8M
Founded Date:
2004
Last Funding Type:
Post-IPO Equity